(2022) Determination of a cost-effectiveness threshold for cancer interventions in Iran. Frontiers in Oncology. p. 9. ISSN 2234-943X

(2022) Estimating Utility Values for Health States of DFU Patients Using EQ-5D-5L and cTTO. International Journal of Lower Extremity Wounds. pp. 41-49. ISSN 1534-7346

(2022) Psychometric properties of the EQ-5D-5L compared with EQ-5D-3L in cancer patients in Iran. Frontiers in Oncology. p. 11. ISSN 2234-943X

(2022) Relationship between sperm quality and total fertilization failure in intracytoplasmic sperm injection and in vitro fertilization cycles: A cross-sectional study. International Journal of Reproductive BioMedicine. pp. 413-422.

(2021) Exploring the consistency of the SF-6Dv2 in a breast cancer population. Expert Review of Pharmacoeconomics & Outcomes Research. pp. 1017-1024. ISSN 1473-7167

(2021) Mapping the cancer-specific FACT-B onto the generic SF-6Dv2. Breast Cancer. pp. 130-136.

(2021) Psychometric properties of the SF-6Dv2 in an Iranian breast cancer population. Breast Cancer. pp. 937-943.

(2020) Comparing the performance of the EQ-5D-5L with two versions of the SF-6Dv2 in patients with breast cancer. Health Services and Outcomes Research Methodology. pp. 183-194. ISSN 1387-3741

(2020) Health-Related Quality of Life and its Associated Factors in COVID-19 Patients. Osong Public Health and Research Perspectives. pp. 296-302. ISSN 2210-9099

(2020) Interim value set for the EQ-5D-5L in Iran using the Crosswalk method. Medical Journal of the Islamic Republic of Iran. p. 121. ISSN 1016-1430 (Print) 2251-6840 (Electronic) 1016-1430 (Linking)

(2019) Assessing the performance of direct and indirect utility eliciting methods in patients with colorectal cancer: EQ-5D-5L versus C-TTO. Health Services and Outcomes Research Methodology. pp. 259-270. ISSN 1387-3741